- Home
- TEVA vs EIX Comparison
TEVA vs EIX Comparison
Compare TEVA & EIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEVA
- EIX
- Stock Information
- Founded
- TEVA 1901
- EIX 1886
- Country
- TEVA Israel
- EIX United States
- Employees
- TEVA N/A
- EIX N/A
- Industry
- TEVA Biotechnology: Pharmaceutical Preparations
- EIX Electric Utilities: Central
- Sector
- TEVA Health Care
- EIX Utilities
- Exchange
- TEVA Nasdaq
- EIX Nasdaq
- Market Cap
- TEVA 20.1B
- EIX 18.6B
- IPO Year
- TEVA N/A
- EIX N/A
- Fundamental
- Price
- TEVA $16.87
- EIX $50.48
- Analyst Decision
- TEVA Strong Buy
- EIX Buy
- Analyst Count
- TEVA 8
- EIX 15
- Target Price
- TEVA $24.50
- EIX $76.82
- AVG Volume (30 Days)
- TEVA 10.1M
- EIX 4.7M
- Earning Date
- TEVA 07-30-2025
- EIX 07-31-2025
- Dividend Yield
- TEVA N/A
- EIX 6.55%
- EPS Growth
- TEVA N/A
- EIX 209.72
- EPS
- TEVA N/A
- EIX 7.04
- Revenue
- TEVA $16,616,000,000.00
- EIX $17,332,000,000.00
- Revenue This Year
- TEVA $5.69
- EIX $8.61
- Revenue Next Year
- TEVA N/A
- EIX $3.68
- P/E Ratio
- TEVA N/A
- EIX $7.18
- Revenue Growth
- TEVA 3.82
- EIX 5.36
- 52 Week Low
- TEVA $12.47
- EIX $47.73
- 52 Week High
- TEVA $22.80
- EIX $88.77
- Technical
- Relative Strength Index (RSI)
- TEVA 48.65
- EIX 42.83
- Support Level
- TEVA $16.55
- EIX $50.36
- Resistance Level
- TEVA $17.30
- EIX $53.24
- Average True Range (ATR)
- TEVA 0.42
- EIX 1.21
- MACD
- TEVA -0.05
- EIX 0.37
- Stochastic Oscillator
- TEVA 34.35
- EIX 48.93
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
About EIX Edison International
Edison International is the parent company of Southern California Edison, an electric utility that distributes electricity to 5 million customers in a 50,000-square-mile area of Southern California, excluding Los Angeles. Edison Energy owns interests in nonutility businesses that deal in energy-related products and services. In 2014, Edison International sold its wholesale power generation subsidiary Edison Mission Energy out of bankruptcy to NRG Energy.